COMMUNIQUÉS West-GlobeNewswire

Cocrystal Pharma Provides Update on Reverse Stock Split
23/01/2018
- Reverse stock split to be effective on Wednesday, January 24, 2018 on split-adjusted basis under trading symbol “COCPD” - ATLANTA, GA and BOTHELL, WA, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (OTCQB: [...]
MacroGenics Announces Continuation of SOPHIA Study of Margetuximab Based on Completion of Interim Futility Analysis
23/01/2018
Rockville, MD, Jan. 23, 2018 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (NASDAQ: MGNX ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics [...]
Strongbridge Biopharma plc Announces Proposed Public Offering of 5 Million Ordinary Shares
23/01/2018
DUBLIN, Ireland and TREVOSE, Pa., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP ) (the “Company”) today announced that it intends to offer and sell 5 million of its ordinary shares in an [...]
UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option
23/01/2018
RA’ANANA, Israel and NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]
Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
23/01/2018
CAMBRIDGE, Mass., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO ) today announced the closing of its previously announced underwritten public offering of common stock, including the [...]
HTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
23/01/2018
TUCSON, Ariz., Jan. 23, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM ) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced the [...]
Five Prime Announces Proposed Public Offering of Common Stock
23/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq: FPRX ), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology [...]
Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer
23/01/2018
DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of [...]
Trident Brands Appoints Senior Industry Executive Bob Dufour To Advisory Board
23/01/2018
BROOKFIELD, WI, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Trident Brands, Inc. (OTCQB: TDNT), a consumer products company focused on novel and unique branded products, private label manufacturing and proprietary innovation [...]
United American Healthcare Corporation Reports Strong Income Growth in Q3 Fiscal Year 2017 Propelled by Performance of its Wholly Owned Subsidiaries
23/01/2018
CHICAGO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- United American Healthcare Corporation (OTC:UAHC) (the “Company” or “UAHC Parent”), today announced the release of its unaudited third quarter report ending September 30, 2017 [...]
Barbara Ann Karmanos Cancer Institute receives 2018 Women’s Choice Award® as one of America’s Best Hospitals for Cancer Care & Research
23/01/2018
DETROIT, Jan. 23, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute has been named one of America’s Best Hospitals for Cancer Care & Research by the Women’s Choice Award ® for 2018. Previously, [...]
Nohla Therapeutics Granted Orphan Drug Designation in the European Union for NLA101 in the Treatment of Hematopoietic Stem Cell Transplantation
23/01/2018
SEATTLE, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a clinical stage biopharmaceutical company focused on the development of universal donor, off-the-shelf cell therapies to treat cancer and [...]
Premier Biomedical Launches Hemp Oil Based Topical Pain Relief Ointment
23/01/2018
JACKSON CENTER, Pa., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) announced introduction of a new hemp oil based topical ointment to complement its existing topical pain relief products, which [...]
Cynata Executes MoU for Commercial Evaluation with Celularity, Inc.
23/01/2018
MoU signed with Celularity, Inc. for the evaluation of and identification of commercial opportunities for the Cymerus TM platform and Celularity’s leading cell therapy assets Follows encouraging early clinical data in [...]
Shire Continues to Uphold High Standards of Ethics and Transparency with Adoption of Open Access Policy for Publication of Shire-Supported Research
23/01/2018
Shire Continues to Uphold High Standards of Ethics and Transparency with Adoption of Open Access Policy for Publication of Shire-Supported Research Cambridge, MA - January 23, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG), [...]
HIFU for Prostate Cancer Now Available at Chesapeake Urology
23/01/2018
CHARLOTTE, N.C., Jan. 23, 2018 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC, the leading provider of HIFU technology to physician practices in the United States, is excited to announce a partnership with Chesapeake [...]
AFA: Signing of New RAISE Family Caregiver Law Positive Step, But Continued Action Needed from Washington
23/01/2018
NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) heralded the signing of the new RAISE Family Caregiver Act, which will provide a desperately needed comprehensive national plan for [...]
K2M Group Holdings, Inc. to Release Fourth Quarter and Fiscal Year 2017 Financial Results on February 28th
23/01/2018
LEESBURG, Va., Jan. 23, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Cocrystal Pharma Announces 1-for-30 Reverse Stock Split
23/01/2018
– Reverse stock split positions Company to uplist to the NASDAQ Capital Market in Q1 2018 – – Company expects to commence Phase 2a study in Q1 2018 for lead program, CC-31244, for the treatment of hepatitis C infection [...]

Pages